Can Finerenone Alter Glomerular Disease Trajectory? - Top-Institutions - MDSpire

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

  • By

  • Kathryn Wighton

  • June 5, 2026

  • 4 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    The George Institute for Global Health
    The George Institute for Global Health

    Sydney, New South Wales

    Key Differentiators

    • Nephrology

  • #2

    University of New South Wales
    University of New South Wales

    Sydney, New South Wales

    Key Differentiators

    • Nephrology

  • #3

    University Medical Center Groningen
    University Medical Center Groningen

    Groningen, Groningen

    Key Differentiators

    • Nephrology

  • #4

    University of Glasgow
    University of Glasgow

    Glasgow, Scotland

    Key Differentiators

    • Nephrology

  • #5

    Osaka University Graduate School of Medicine
    Osaka University Graduate School of Medicine

    Osaka, Osaka

    Key Differentiators

    • Nephrology

Original Source(s)

Can Finerenone Alter Glomerular Disease Trajectory?

  • by Kathryn Wighton

  • June 5, 2026

Related Content

Recognizing the Transition to Advanced Heart Failure Earlier

Despite major advances in guideline-directed medical therapy (GDMT), worsening heart failure continues to drive significant morbidity, repeat hospitalizations and healthcare utilization worldwide.

  • May 27, 2026

  • 6 min
The role of albumin–globulin ratio in peripheral arterial disease among hypertensive adults: evidence from a large-scale multicenter study

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure